Literature DB >> 12709289

Prostate Testing for Cancer and Treatment (ProtecT) feasibility study.

J Donovan1, F Hamdy, D Neal, T Peters, S Oliver, L Brindle, D Jewell, P Powell, D Gillatt, D Dedman, N Mills, M Smith, S Noble, A Lane.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12709289     DOI： 10.3310/hta7140

Source DB:  PubMed          Journal:  Health Technol Assess        ISSN： 1366-5278            Impact factor:   4.014


× No keyword cloud information.
  65 in total

1.  Consideration of the likely benefit from implementation of prostate image-guided radiotherapy using current margin sizes: a radiobiological analysis.

Authors:  G S J Tudor; Y L Rimmer; T B Nguyen; M A Cowen; S J Thomas
Journal:  Br J Radiol       Date:  2012-02-14       Impact factor: 3.039

2.  Screening for prostate cancer in younger men.

Authors:  Dragan Ilic; Sally Green
Journal:  BMJ       Date:  2007-11-15

3.  Life course sun exposure and risk of prostate cancer: population-based nested case-control study and meta-analysis.

Authors:  Rebecca Gilbert; Chris Metcalfe; Steven E Oliver; David C Whiteman; Chris Bain; Andy Ness; Jenny Donovan; Freddie Hamdy; David E Neal; J Athene Lane; Richard M Martin
Journal:  Int J Cancer       Date:  2009-09-15       Impact factor: 7.396

4.  Stage shift in PSA-detected prostate cancers - effect modification by Gleason score.

Authors:  Nora Pashayan; Paul Pharoah; David E Neal; Freddie Hamdy; Jenny Donovan; Richard M Martin; David Greenberg; Stephen W Duffy
Journal:  J Med Screen       Date:  2009       Impact factor: 2.136

5.  Modeling grade progression in an active surveillance study.

Authors:  Lurdes Y T Inoue; Bruce J Trock; Alan W Partin; Herbert B Carter; Ruth Etzioni
Journal:  Stat Med       Date:  2013-10-09       Impact factor: 2.373

Review 6.  What is low-risk prostate cancer and what is its natural history?

Authors:  Helen O'Donnell; Chris Parker
Journal:  World J Urol       Date:  2008-06-21       Impact factor: 4.226

7.  Mutation analysis of the MSMB gene in familial prostate cancer.

Authors:  Z Kote-Jarai; D Leongamornlert; M Tymrakiewicz; H Field; M Guy; A A Al Olama; J Morrison; L O'Brien; R Wilkinson; A Hall; E Sawyer; K Muir; F Hamdy; J Donovan; D Neal; D Easton; R Eeles
Journal:  Br J Cancer       Date:  2009-12-08       Impact factor: 7.640

8.  Associations between an obesity related genetic variant (FTO rs9939609) and prostate cancer risk.

Authors:  Sarah J Lewis; Ali Murad; Lina Chen; George Davey Smith; Jenny Donovan; Tom Palmer; Freddie Hamdy; David Neal; J Athene Lane; Michael Davis; Angela Cox; Richard M Martin
Journal:  PLoS One       Date:  2010-10-19       Impact factor: 3.240

9.  Current strategies for monitoring men with localised prostate cancer lack a strong evidence base: observational longitudinal study.

Authors:  C Metcalfe; K Tilling; M Davis; J A Lane; R M Martin; H Kynaston; P Powell; D E Neal; F Hamdy; J L Donovan
Journal:  Br J Cancer       Date:  2009-07-14       Impact factor: 7.640

10.  The routine use of prostate-specific antigen for early detection of cancer prostate in India: Is it justified?

Authors:  Deepak Dubey
Journal:  Indian J Urol       Date:  2009-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.